Clin Psychopharmacol Neurosci.  2018 May;16(2):221-223. 10.9758/cpn.2018.16.2.221.

Successful Treatment with Olanzapine of Psychosis in Dentatorubral-pallidoluysian Atrophy: A Case Report

Affiliations
  • 1Department of Psychiatry, National Center Hospital, National Center of Neurology and Psychiatry, Tokyo, Japan. zuinarita@ncnp.go.jp
  • 2Department of Clinical Epidemiology, Translational Medical Center, National Center of Neurology and Psychiatry, Tokyo, Japan.

Abstract

Patients with dentatorubral-pallidoluysian atrophy occasionally elicit psychosis. So far, one study reported first generation antipsychotics drugs may provide an effective treatment; however, there is no literature on the benefits of second generation antipsychotics. We report on a 44-year-old man with dentatorubral-pallidoluysian atrophy whose psychotic symptoms were effectively treated with olanzapine. Our observation suggests some second generation antipsychotics provide a therapeutic option for ameliorating psychosis in dentatorubral-pallidoluysian atrophy.

Keyword

Progressive myoclonic epilepsies; Spinocerebellar degenerations; Psychosis; Antipsychotics
Full Text Links
  • CPN
Share
  • Twitter
  • Facebook
Copyright © 2020 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr